Physical Activity Program Referral for Chronic Disease
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial examines how effectively clinics and their patients can adopt a new physical activity program. It aims to determine if referring patients to a 12-week exercise plan can be easily implemented and effective in a community setting. Patients referred by their primary care provider since September 5, 2023, might be suitable candidates. The trial includes clinics that choose to adopt the program and those that do not, to compare outcomes. As an unphased trial, it offers patients the chance to contribute to innovative community health solutions.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this physical activity program is safe for participants?
Research has shown that physical activity, such as that encouraged by the Exercise is Medicine (EIM) program, is generally safe for most people. Studies have found that exercise helps prevent and treat many long-term illnesses. Most participants have handled it well, with few reports of negative effects. The EIM program promotes regular exercise, which many people can do safely with the right guidance. Always consult a healthcare provider to ensure a new exercise routine suits your health.12345
Why are researchers excited about this trial?
Researchers are excited about the Physical Activity Program Referral for Chronic Disease trial because it explores the impact of encouraging clinics to adopt a structured exercise program, which differs from the usual care of medication and lifestyle advice. Unlike current options that primarily focus on managing symptoms with drugs or general guidance, this program offers a direct referral to a physical activity regimen, aiming to integrate exercise as a key component of chronic disease management. This approach could lead to better patient engagement and long-term health improvements by making exercise a routine part of care.
What evidence suggests that this trial's physical activity program could be effective for chronic disease?
Research has shown that exercise can be as effective as medication for managing chronic diseases like heart disease and high blood pressure. Many studies support this, demonstrating that physical activity helps prevent and treat these conditions. This trial will evaluate the Exercise is Medicine (EIM) program, which builds on these findings. Clinics will either adopt the EIM program or not, forming separate study arms. The program customizes to meet the specific needs and readiness of participants, ensuring maximum benefit. This approach has successfully encouraged more people to be active and improve their health.12467
Who Is on the Research Team?
Jennifer L Trilk, PhD
Principal Investigator
University of South Carolina
Mark Stoutenberg, PhD
Principal Investigator
Durham University
Are You a Good Fit for This Trial?
This trial is for patients who visit Prisma Health primary care clinics in South Carolina, have not been part of EIMG onboarding or activation before, and are within 15 miles of a local community physical activity facility. Clinics with at least two attending providers can participate.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Initial Implementation
Initial implementation and reach of EIMG at adopting clinics tracked following the dissemination of the pre-recorded training video
Onboard Training and Implementation
In-depth, standardized clinic onboard training provided, followed by tracking of EIMG implementation and reach
Community-based Physical Activity Program
Referred patients enroll in a 12-week evidence-informed physical activity program at local community facilities
Follow-up
Participants are monitored for changes in health outcomes and healthcare costs post-program
What Are the Treatments Tested in This Trial?
Interventions
- Invitation to adopt
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of South Carolina
Lead Sponsor
Durham University
Collaborator
University of Nebraska
Collaborator
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator
Temple University
Collaborator
University of Utah
Collaborator